Log in
Registration
Українська
English
Search for:
Home
Online Publication
Current Issue
Issue Archive
Authors
About
Information About the Journal
Focus and Scope
Indexing
For Authors
Submission Guidelines and Requirements
Peer Review
Article Processing Charges
Copyright and Licensing
Policies
Editorial Policy
Plagiarism Policy
Archiving Policy
Policy on the Use of Artificial Intelligence (AI) and AI-Supported Technologies
Open Access
Procedure for the Retraction of Published Articles
Ethical Issues
Publication Ethics
Procedure for Handling Complaints Regarding Ethical Breaches
Privacy Statement
International Standards and Principles of Operation
Organization of anticancer fight
Tumors of the chest cavity
Tumors of abdominal organs
Tumors of skin, soft tissues, bones
Breast tumor
Oncogynecology
Tumors of the head and neck
Oncurology
Oncohematology
Radiation diagnostics, radiation therapy
Experimental studies
Magazine online
All news
Author : Lyalkin S.
Current state of hormone therapy in patients with metastatic breast cancer
Authors: Tarasenko T. Syvak L. Lyalkin S. Verovkina N.O.... Т. 12, № 1-2 (45-46)
Effect of chemokin polymorphisms on the efficacy of chemotherapy in patients with Her2/neu-negative breast cancer
Authors: Syvak L. Verovkina N.O. Lyalkin S. Tarasenko T.... Т. 11, № 3-4 (43-44)
Prognostic factors of metastatic luminal (Her2/neu-negative) breast cancer
Authors: Tarasenko T. Syvak L. Verevkina N. Lyalkin S.... T. 10, № 1-2 (37-38)
Role of TLR-2, TLR-4, TLR-9 gene polymorphism in prognosis of triple negative breast cancer
Authors: Lyalkin S. Sivak L.A. Khranovska N.M. Verovkina N.O. Т. 9, № 2 (34) 2019
The role of ESR1 mutations in development of resistance to hormone therapy in patients with luminal subtypes of breast cancer
Authors: Sivak L.A. Tarasenko T. Lyalkin S. Verevkina N. Т. 8, № 1 (29) 2018
Preservation of fertility in patients with breast cancer
Authors: Sivak L.A. Lyalkin S. Martynyuk O. Dosenko I.... Т. 8, № 1 (29) 2018
In situ immune response after perioperative chemotherapy in patients with locally advanced breast cancer
Authors: Verovkina N.O. Sivak L.A. Lyalkin S. Krotevych M.S. №3(27) 2017
The influence of allelic polymorphism of the gene CCR5 on the course of locally advanced breast cancer
Authors: Sivak L.A. Verevkina N. Gorovenko N.G. Lyalkin S.... №1(25) 2017
Modern approaches to the treatment of inoperable non-small cell lung cancer
Authors: Klimаnоv М.Yu. Sivak L.A. Tarasenko T. Askоlskiy А.В.... №4(24) 2016
The clinical case of multiple primary cancer
Authors: Sivak L.A. Tarasenko T. Klimаnоv М.Yu. Lyalkin S.... №3(23) 2016
Prognostic and predictive value of the biological markers in locally advanced breast cancer
Authors: Sivak L.A. Verevkina N. Lyalkin S. Mаydаnеvich N.... №4(20) 2015
Breast cancer prognostic factors. Current state of the problem
Authors: Sivak L.A. Verevkina N. Lyalkin S. №4(16) 2014
Prognosis of breast cancer course by identifying gene intersektyn ITSN2
Authors: Sivak L.A. Kryachok I. Gubareva G.O. Lyalkin S.... №3(15) 2014
Effectiveness of support therapy algorithms based on chemotherapy toxicity prognostic factors in patients with breast cancer
Authors: Sivak L.A. Gubareva G.O. Lyalkin S. Mаydаnеvich N.... №1(13) 2014
Triple negative breast cancer: current view on the problem
Authors: Sivak L.A. Lyalkin S. Mаydаnеvich N. Klimаnоv М.Yu.... №3(11) 2013
1
2
»